Novasome: Combining Ufasome and Niosome for Excellent Vesicular Drug Delivery System
Open Access
- 18 October 2022
- journal article
- Published by Etflin in Sciences of Pharmacy
- Vol. 2 (1), 35-49
- https://doi.org/10.58920/sciphar02010035
Abstract
Novasome technology is a novel encapsulation-based drug delivery method that is more effective and efficient than standard liposome systems. It is composed of a mixture of surfactant, cholesterol, and free fatty acids, which produce superior vesicle characteristics for drug delivery. Various studies have investigated the optimal combination of surfactant type, free fatty acid type, and their ratio, as well as the formulation factors that can significantly affect the vesicle characteristics. The novasome technology has demonstrated its potential for delivering a range of substances, including terconazole, fenticonazole, zolmitriptan, and vaccines. Novasomes can be produced using various methods, such as the thin film hydration (TFH) method, injection method, and vortex method combined with a suitable size reduction method. Future research can focus on exploring the potential of novasome technology for delivering a wider range of drugs and vaccines and developing more efficient and effective methods for producing novasome vesicles.Keywords
This publication has 46 references indexed in Scilit:
- Model Systems of Precursor Cellular Membranes: Long-Chain Alcohols Stabilize Spontaneously Formed Oleic Acid VesiclesBiophysical Journal, 2012
- Influence of the Flexible Liposomes on the Skin Deposition of a Hydrophilic Model Drug, Carboxyfluorescein: Dependency on Their CompositionThe Scientific World Journal, 2012
- Microparticulate Based Topical Delivery System of Clobetasol PropionateAAPS PharmSciTech, 2011
- Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle–skin interactionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Development and characterization of oleic acid vesicles for the topical delivery of fluconazoleDrug Delivery, 2010
- Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenzaVaccine, 2007
- Formation and Properties of Fatty Acid Vesicles (Liposomes)Published by Taylor & Francis Ltd ,2006
- Adjuvant properties of non-phospholipid liposomes (Novasomes®) in experimental animals for human vaccine antigensVaccine, 1996
- Engineering liposomes for drug delivery: progress and problemsTrends in Biotechnology, 1995
- Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85)International Journal of Pharmaceutics, 1994